Entrepreneur
JANSSEN-CILAG, S.A.
ESP / Madrid / 28042
Total attribué
€21M
Avis remportés
22
Lots remportés
88
Dernière attribution
09 juil. 2026
Lots attribués
| Lot | CPV | Nature du contrat | Valeur attribuée | Valeur estimée | Lieu | Critères d'attribution |
|---|---|---|---|---|---|---|
LOT-0001 / Lote 1: Fármacos exclusivos de Janssen-Cilag de consumo actual en el Hospital. | Various medicinal products | supplies | €77.8M | €93.4M | ESP / Barcelona | price |
LOT-0001 / 1 - L1_USTEKINUMAB (DOE) | Pharmaceutical products | supplies | €19.3M | - | - | price |
LOT-0002 / Suministro sucesivo del medicamento Daratumumab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €17.9M | €39.4M | ESP / Santiago de Compostela | price / 100 |
LOT-0031 / stelara 90 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €8.55M | - | - | price |
LOT-0031 / stelara 90 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €8.55M | - | - | price |
LOT-0002 / Lote 2: Fármacos exclusivos de Janssen-Cilag de consumo futuro en el Hospital. | Various medicinal products | supplies | €7.32M | €8.79M | ESP / Barcelona | price |
LOT-0012 / stelara 90 mg 1 jeringa precargada 1 ml | Antineoplastic and immunomodulating agents | supplies | €6.42M | 277 319 € | - | price |
LOT-0012 / stelara 90 mg 1 jeringa precargada 1 ml | Antineoplastic and immunomodulating agents | supplies | €6.42M | 277 319 € | - | price |
LOT-0007 / imbruvica 420 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | €5.03M | 556 013 € | - | price |
LOT-0007 / imbruvica 420 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | €5.03M | 556 013 € | - | price |
Afficher 78 lignes de plus
LOT-0013 / stelara 130mg 1 vial concentrado perfusion 26 ml | Antineoplastic and immunomodulating agents | supplies | €2.78M | €1.02M | - | price |
LOT-0013 / stelara 130mg 1 vial concentrado perfusion 26 ml | Antineoplastic and immunomodulating agents | supplies | €2.78M | €1.02M | - | price |
LOT-0022 / symtuza 800 mg/150 mg/200 mg/10 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €2.74M | €13.7M | - | price |
LOT-0022 / symtuza 800 mg/150 mg/200 mg/10 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €2.74M | €13.7M | - | price |
LOT-0025 / tremfya 100 mg 1 pluma solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | €2.63M | €1.98M | - | price |
LOT-0025 / tremfya 100 mg 1 pluma solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | €2.63M | €1.98M | - | price |
LOT-0005 / Suministro sucesivo del medicamento Talquetamab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €1.93M | €4.25M | ESP / Santiago de Compostela | price / 100 |
LOT-0000 / Acuerdo Marco para el suministro de SYMTUZA® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | €1.58M | - | - | quality / 5 |
LOT-0030 / stelara 45 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €1.5M | - | - | price |
LOT-0030 / stelara 45 mg solucion inyectable en pluma precargada | Antineoplastic and immunomodulating agents | supplies | €1.5M | - | - | price |
LOT-0000 / Acuerdo Marco para el suministro de TREVICTA_BYANNLI® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | €1.32M | - | - | quality / 5 |
LOT-0016 / Etravirina 200 mg comprimidos oral | Various medicinal products | supplies | €1.27M | €1.01M | ESP | price / 100 |
LOT-0004 / Trevicta 525 mg | Various medicinal products | supplies | €1.24M | €11.2M | ESP | price / 100 |
LOT-0020 / byannli 1.000 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | €1.24M | €1.91M | - | price |
LOT-0020 / byannli 1.000 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | €1.24M | €1.91M | - | price |
LOT-0006 / Suministro sucesivo del medicamento Teclistamab para los centros hospitalarios de Servicio Gallego de Salud | Antineoplastic agents | supplies | €1.16M | €2.56M | ESP / Santiago de Compostela | price / 100 |
LOT-0011 / stelara 45 mg 1 jeringa precargada 0.5 ml | Antineoplastic and immunomodulating agents | supplies | €1.07M | 171 148 € | - | price |
LOT-0011 / stelara 45 mg 1 jeringa precargada 0.5 ml | Antineoplastic and immunomodulating agents | supplies | €1.07M | 171 148 € | - | price |
LOT-0006 / imbruvica 560 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €1.05M | 272 475 € | - | price |
LOT-0006 / imbruvica 560 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | €1.05M | 272 475 € | - | price |
LOT-0001 / LOTE 2:MEDICAMENTOS ONCOLÓGICOS (I) | General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Antineoplastic agents | supplies | 969 614 € | €22M | ESP / Sabadell | quality / 5 |
LOT-0001 / LOTE 1.SPRAVATO | Pharmaceutical products | supplies | 763 280 € | - | ESP | price |
LOT-0019 / trevicta 525 mg 1 jeringa susp inyect lib prol 2,625 ml | Antineoplastic and immunomodulating agents | supplies | 732 132 € | €14.3M | - | price |
LOT-0019 / trevicta 525 mg 1 jeringa susp inyect lib prol 2,625 ml | Antineoplastic and immunomodulating agents | supplies | 732 132 € | €14.3M | - | price |
LOT-0021 / byannli 700 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | 650 784 € | €3.08M | - | price |
LOT-0021 / byannli 700 mg suspension inyectable liberacion 1 jeringa precargada | Antineoplastic and immunomodulating agents | supplies | 650 784 € | €3.08M | - | price |
LOT-0024 / tremfya 100 mg 1 jeringa solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | 592 740 € | €1.83M | - | price |
LOT-0024 / tremfya 100 mg 1 jeringa solucion inyectable 1 ml | Antineoplastic and immunomodulating agents | supplies | 592 740 € | €1.83M | - | price |
LOT-0003 / Trevicta 350 mg | Various medicinal products | supplies | 554 422 € | €5M | ESP | price / 100 |
LOT-0008 / imbruvica 280 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | 523 990 € | €5.56M | - | price |
LOT-0008 / imbruvica 280 mg 30 comprimidos | Medicinal products for the blood, blood-forming organs and the cardiovascular system | supplies | 523 990 € | €5.56M | - | price |
LOT-0017 / Rilpivirina 25 mg comprimidos oral | Various medicinal products | supplies | 457 912 € | €1.58M | ESP | price / 100 |
LOT-0028 / spravato 28 mg solucion pulverizacion nasal | Antineoplastic and immunomodulating agents | supplies | 381 640 € | €44.5M | - | price |
LOT-0028 / spravato 28 mg solucion pulverizacion nasal | Antineoplastic and immunomodulating agents | supplies | 381 640 € | €44.5M | - | price |
LOT-0023 / rezolsta 800/150mg 30 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 366 656 € | 91 749 € | - | price |
LOT-0023 / rezolsta 800/150mg 30 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 366 656 € | 91 749 € | - | price |
LOT-0027 / ponvory 20 mg 28 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 352 880 € | €7.78M | - | price |
LOT-0027 / ponvory 20 mg 28 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 352 880 € | €7.78M | - | price |
LOT-0002 / Apalutamida 240mg oral | Various medicinal products | supplies | 325 926 € | 340 740 € | ESP | price / 100 |
LOT-0002 / Trevicta 263 mg | Various medicinal products | supplies | 282 681 € | €2.55M | ESP | price / 100 |
LOT-0018 / trevicta 350 mg 1 jeringa susp inyect lib prol 1,75 ml | Antineoplastic and immunomodulating agents | supplies | 271 160 € | €4.88M | - | price |
LOT-0018 / trevicta 350 mg 1 jeringa susp inyect lib prol 1,75 ml | Antineoplastic and immunomodulating agents | supplies | 271 160 € | €4.88M | - | price |
LOT-0000 / suministro del medicamento SIRTURO 100 mg comprimido oral principio activo BEDAQUILINA, SPRAVATO 28 mg solución PULVERIZ NASAL principio activo ESKETAMINA, Y PONVORY 20 mg comprimido oral, principio activo PONESIMOD, con destino Servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria | Various medicinal products | supplies | 267 102 € | - | - | price / 100 |
LOT-0001 / Trevicta 175 mg | Various medicinal products | supplies | 226 454 € | €2.04M | ESP | price / 100 |
LOT-0000 / Acuerdo Marco para el suministro de REZOLSTA® a los centros penitenciarios dependientes de la Secretaría General de Instituciones Penitenciarias. | Pharmaceutical products | supplies | 214 494 € | - | - | quality / 5 |
LOT-0001 / Suministro de Ponesimod (DOE) | Pharmaceutical products | supplies | 190 555 € | - | - | price |
LOT-0016 / trevicta 175 mg 1 jeringa susp inyect lib prol 0,875 ml | Antineoplastic and immunomodulating agents | supplies | 135 580 € | €5.5M | - | price |
LOT-0016 / trevicta 175 mg 1 jeringa susp inyect lib prol 0,875 ml | Antineoplastic and immunomodulating agents | supplies | 135 580 € | 272 475 € | - | price |
LOT-0002 / 2 - L2_RILPIVIRINA (DOE) | Pharmaceutical products | supplies | 131 305 € | - | - | price |
LOT-0017 / trevicta 263 mg 1 jeringa susp inyect lib prol 1,315 ml | Antineoplastic and immunomodulating agents | supplies | 122 253 € | €9.3M | - | price |
LOT-0017 / trevicta 263 mg 1 jeringa susp inyect lib prol 1,315 ml | Antineoplastic and immunomodulating agents | supplies | 122 253 € | €9.3M | - | price |
LOT-0010 / stelara 45mg 1 vial solucion inyectable | Antineoplastic and immunomodulating agents | supplies | 106 926 € | €14.5M | - | price |
LOT-0010 / stelara 45mg 1 vial solucion inyectable | Antineoplastic and immunomodulating agents | supplies | 106 926 € | €14.5M | - | price |
LOT-0029 / sirturo 100mg 24 comprimidos | Antineoplastic and immunomodulating agents | supplies | 95 740 € | - | - | price |
LOT-0029 / sirturo 100mg 24 comprimidos | Antineoplastic and immunomodulating agents | supplies | 95 740 € | 37 419 € | - | price |
LOT-0015 / dacogen 50mg 1 vial polvo concentrado solucion perfusion | Antineoplastic and immunomodulating agents | supplies | 53 331 € | €2.04M | - | price |
LOT-0015 / dacogen 50mg 1 vial polvo concentrado solucion perfusion | Antineoplastic and immunomodulating agents | supplies | 53 331 € | €2.04M | - | price |
LOT-0001 / 1 - PONVORY | Pharmaceutical products | supplies | 52 932 € | 52 941 € | ESP / Logroño | cost / 100 |
LOT-0009 / imbruvica 140 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | 52 399 € | €33.4M | - | price |
LOT-0009 / imbruvica 140 mg 30 comprimidos | Antineoplastic and immunomodulating agents | supplies | 52 399 € | €33.4M | - | price |
LOT-0004 / edurant 25mg 30 comprimidos recubiertos pelicula | Antineoplastic and immunomodulating agents | supplies | 41 684 € | €26.2M | - | price |
LOT-0004 / edurant 25mg 30 comprimidos recubiertos pelicula | Antineoplastic and immunomodulating agents | supplies | 41 684 € | €26.2M | - | price |
LOT-0020 / Apalutamida 60 mg comprimidos oral | Various medicinal products | supplies | 34 720 € | €8.42M | ESP | price / 100 |
LOT-0014 / intelence 200 mg 60 comprimidos | Antineoplastic and immunomodulating agents | supplies | 32 913 € | 917 608 € | - | price |
LOT-0014 / intelence 200 mg 60 comprimidos | Antineoplastic and immunomodulating agents | supplies | 32 913 € | 917 608 € | - | price |
LOT-0003 / Etravirina 200mg oral | Various medicinal products | supplies | 18 147 € | 19 748 € | ESP | price / 100 |
LOT-0026 / ponvory 2-3-4-5-6-7-8-9-10 mg 14 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 17 644 € | 497 874 € | - | price |
LOT-0026 / ponvory 2-3-4-5-6-7-8-9-10 mg 14 comprimidos recubiertos con pelicula | Antineoplastic and immunomodulating agents | supplies | 17 644 € | 497 874 € | - | price |
LOT-0001 / Apalutamida 60mg oral | Various medicinal products | supplies | 14 815 € | 15 488 € | ESP | price / 100 |
LOT-0001 / TREVICTA 263 MG SUSPENSION INYECTABLE LIBERACION PROLONGADA JERINGA | Pharmaceutical products | supplies | 8 823 € | - | ESP | cost |
LOT-0000 / TREVICTA 175 MG SUSPENSION INYECTABLE LIBERACION PROLONGADA JERINGA | Pharmaceutical products | supplies | 5 871 € | - | ESP | cost |
LOT-0001 / Suministro sucesivo del medicamento CILTACABTAGÉN AUTOLEUCEL | Antineoplastic agents | supplies | - | €86.8M | ESP / Vigo | cost |
LOT-0003 / Darunavir / Cobicistat comprimidos (800 / 150) mg, Etravirina comprimidos 200 mg, Rilpivirina comprimidos 25 mg | Antivirals for systemic use | supplies | - | €10.1M | ESP | price / 100 |
LOT-0001 / Suministro sucesivo del medicamento "CILTACABTAGEN AUTOLEUCEL". | Antineoplastic agents | supplies | - | €86.8M | ESP / A Coruña | cost |
LOT-0001 / UPTRAVI 1200 MCG 60 COMP. | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0002 / INTELENCE 200 MG 60 COMP. | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0004 / SPRAVATO 28 MG SOLUCION PARA PULVERIZACION NASAL | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0002 / Lote 8 AM SUM | Various medicinal products Pharmaceutical products | supplies | - | - | ESP | price |
Marchés attribués
Afficher 12 lignes de plus
Détails de l'entreprise
Identifiants
A28925899
Pays
ESP
Villes
Madrid
Codes postaux
28042
E-mails
Sites web
Codes CPV
Taille
large
À propos de cet entrepreneur
JANSSEN-CILAG, S.A. est un entrepreneur auquel des marchés publics publiés dans les systèmes européens officiels de passation des marchés ont été attribués.
Ce profil résume les informations de marchés publics disponibles publiquement, notamment la valeur des contrats attribués, les lots attribués, l'historique des achats, les pays d'activité, les classifications CPV et les attributions récentes.
FAQ
Quelles informations ce profil d'entrepreneur contient-il ?
Ce profil résume les informations de marchés publics disponibles publiquement concernant l'entrepreneur, notamment les valeurs des contrats attribués, les lots attribués, l'historique des achats, les classifications CPV, les lieux et les détails de l'entreprise lorsqu'ils sont disponibles.
Que signifie Total attribué ?
Total attribué représente la valeur totale connue des contrats attribués associés à cet entrepreneur sur la base des données de marchés publics disponibles.
Pourquoi la valeur attribuée peut-elle différer de la valeur totale du contrat ?
Un entrepreneur peut se voir attribuer un ou plusieurs lots dans une procédure de passation de marché. Par conséquent, la valeur attribuée à l'entrepreneur peut différer de la valeur totale de l'avis de marché.
Que sont les lots attribués ?
Les lots attribués sont des parties individuelles d'une procédure de passation de marché qui ont été attribuées à cet entrepreneur.
À quelle fréquence ce profil est-il mis à jour ?
Les profils d'entrepreneurs sont mis à jour automatiquement lorsque de nouveaux avis de marchés publics et avis d'attribution deviennent disponibles.
Pourquoi certains détails de l'entreprise manquent-ils ?
Les profils d'entrepreneurs sont générés à partir d'avis de marchés publics accessibles au public. Certaines informations, comme les coordonnées ou les données d'enregistrement de l'entreprise, peuvent ne pas être disponibles dans chaque avis.
Comprendre ce profil d'entrepreneur
Ce profil d'entrepreneur est généré à partir d'informations de marchés publics accessibles au public et publiées par les pouvoirs adjudicateurs.
Le profil aide les professionnels des achats, les fournisseurs, les chercheurs et les journalistes à comprendre la participation d'un entrepreneur aux marchés publics.
Les informations peuvent inclure les valeurs des contrats attribués, les lots attribués, l'historique des achats, les catégories d'achat (CPV), les lieux et les pouvoirs adjudicateurs.